Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-06-06
DOI
10.3389/fphar.2022.921493
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Comprehensive Review of Cannabis Potency in the USA in the Last Decade
- (2021) Mahmoud A. ElSohly et al. Biological Psychiatry-Cognitive Neuroscience and Neuroimaging
- Trends and Characteristics of Manufactured Cannabis Product and Cannabis Plant Product Exposures Reported to US Poison Control Centers, 2017-2019
- (2021) Julia A. Dilley et al. JAMA Network Open
- Mapping cannabis potency in medical and recreational programs in the United States
- (2020) Mary Catherine Cash et al. PLoS One
- CBD and THC: Do they complement each other like yin and yang?
- (2020) Sarah D. Pennypacker et al. PHARMACOTHERAPY
- Brief Commentary: Cannabinoid Dosing for Chronic Pain Management
- (2019) Kevin F. Boehnke et al. ANNALS OF INTERNAL MEDICINE
- A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects
- (2019) Nadia Solowij et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Qualifying Conditions Of Medical Cannabis License Holders In The United States
- (2019) Kevin F. Boehnke et al. HEALTH AFFAIRS
- New trends in cannabis potency in USA and Europe during the last decade (2008–2017)
- (2019) Suman Chandra et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
- (2019) Thomas R. Arkell et al. PSYCHOPHARMACOLOGY
- High frequency medical cannabis use is associated with worse pain among individuals with chronic pain
- (2019) Kevin F. Boehnke et al. JOURNAL OF PAIN
- The Form and Content of Cannabis Products in the United States
- (2018) Stacey Steigerwald et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Cannabis for Chronic Pain: Challenges and Considerations
- (2018) E. Alfonso Romero-Sandoval et al. PHARMACOTHERAPY
- An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia
- (2018) Tine van de Donk et al. PAIN
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changes in Cannabis Potency Over the Last 2 Decades (1995–2014): Analysis of Current Data in the United States
- (2016) Mahmoud A. ElSohly et al. BIOLOGICAL PSYCHIATRY
- An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease
- (2016) Barth Wilsey et al. JOURNAL OF PAIN
- Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data
- (2015) Michael H. Andreae et al. JOURNAL OF PAIN
- Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy
- (2015) Mark S. Wallace et al. JOURNAL OF PAIN
- A systematic review of the antipsychotic properties of cannabidiol in humans
- (2015) Tabitha A. Iseger et al. SCHIZOPHRENIA RESEARCH
- Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?
- (2014) Tom P. Freeman et al. ADDICTION
- Synthetic cannabinoids: Analysis and metabolites
- (2014) Mahmoud A. ElSohly et al. LIFE SCIENCES
- Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
- (2012) Barth Wilsey et al. JOURNAL OF PAIN
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
- (2011) Mateus M Bergamaschi et al. NEUROPSYCHOPHARMACOLOGY
- Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
- (2010) M. A. Ware et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- High-potency cannabis and the risk of psychosis
- (2009) Marta Di Forti et al. BRITISH JOURNAL OF PSYCHIATRY
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
- (2008) Ronald J Ellis et al. NEUROPSYCHOPHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now